P. Brock et al., Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor, CYTOMETRY, 35(4), 1999, pp. 353-362
Background: The analysis of the subcellular distribution of proteins is ess
ential for the understanding of processes such as signal transduction, In m
ost cases, the parallel analysis of multiple components requires fixation a
nd immunofluorescence labeling. Therefore, one has to ascertain that the fi
xation procedure preserves the in vivo protein distribution. Fusion protein
s with the green fluorescent protein (GFP) are ideal tools for this purpose
. However, one must consider specific aspects of the fluorophore formation
or degradation, i.e. reactions that may interfere with the detection of GFP
fusion proteins.
Methods: Fusion proteins of the epidermal growth factor receptor (EGFR) wit
h GFP as well as free, soluble GFP stably or transiently expressed in adher
ent cultured cells served as test cases for comparing the distribution in v
ivo with that after fixation by conventional epifluorescence and laser scan
ning microscopy. Indirect immunofluorescence was employed to compare the di
stributions of the GFP signal and of the GFP polypeptide in the fusion prot
ein.
Results: Paraformaldehyde (PFA) fixation with subsequent mounting in the an
tifading agent Mowiol, but not in Tris- or HEPES buffered saline, led to a
partial redistribution of the EGFR from the plasma membrane to the perinucl
ear region. The redistribution was confirmed with the GFP and EGFR immunofl
uorescence. The in vivo distribution in Mowiol mounted cells was preserved
if cells were treated with a combined PFA/methanol fixation procedure, whic
h also retained the fluorescence of soluble GFP. The anti-GFP antiserum was
negative for the N-terminal fusion protein.
Conclusions: The combined PFA/methanol protocol is universally applicable f
or the fixation of transmembrane and soluble cytoplasmic proteins and prese
rves the fluorescence of GFP. (C) 1999 Wiley-Liss, Inc.